Free Smoking Cessation Program Now Available in Ireland

Events by 2FIRSTS.ai
Jan.10.2024
Free Smoking Cessation Program Now Available in Ireland
HSE encourages smokers to quit by offering free smoking cessation aids including nicotine replacement therapy.

According to a report by Irish media outlet Limerick Post at a certain time, the Irish Health Service Executive (HSE) is actively encouraging people who quit smoking by offering them free smoking cessation aid packages.

 

A spokesperson from the health service department stated, "Many individuals attempting to quit smoking do not receive the necessary support and treatment methods, such as smoking cessation medications, that provide the greatest chances of success. HSE is here to help you quit smoking by offering free nicotine replacement therapy (NRT) along with other tried and tested support options.

 

The smoking cessation service provided by the HSE is free throughout the year and offers personalized, evidence-based plans tailored to individual needs. It provides a range of support options, which can be combined according to individual preferences, such as:

 

Online personalized quit smoking program tracks its progress; face-to-face and group support from the community; SMS or telephone support available through the toll-free line 1800 201 203; free "Quit Smoking Kit" to aid in preparation for quitting; free provision of nicotine replacement therapy (NRT) with usage guidance; daily advice and support from individuals who have successfully quit smoking or are currently attempting to quit on the "You Can Quit Smoking" Facebook page.

 

The Health and Safety Executive (HSE) recommends several strategies for quitting smoking. These include seeking support from others, including HSE's smoking cessation services, rather than fighting the battle alone. The advice is to focus on maintaining a smoke-free status every day until reaching the milestone of 28 days, as this significantly increases the chances of quitting permanently. Additionally, the use of smoking cessation medications such as Nicotine Replacement Therapy (NRT) is suggested as a safe, effective, and clinically viable method to overcome initial cravings and navigate the first 28 days of quitting.

 

Dr. Paul Kavanagh, the Public Health Medicine Advisor in charge of Ireland's Smoke-Free Plan, has clarified that Nicotine Replacement Therapy (NRT) is both safe and effective. "We know that NRT is very safe and also effective," he said. These medications are strictly regulated by the Irish Health Products Regulatory Authority (HPRA).

 

We are encouraged to see an increasing number of smokers using NRT to help them quit smoking. We have been making efforts to improve the accessibility and availability of this life-saving medication. Smokers, those looking to quit, and the healthcare professionals supporting them can have full trust and confidence in the safety and effectiveness of NRT.

 

Some smokers may be curious about using e-cigarettes or e-liquid to help them quit smoking. We do not have sufficient trust and confidence in the safety and efficacy of e-cigarettes as a means of quitting smoking, so we recommend using NRT to assist them in their quit attempts.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.